Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.
Options
BORIS DOI
Publisher DOI
PubMed ID
36635391
Date of Publication
2023-03
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Zander, Thilo | |
Schär, Sämi | |
Aebi, Stefan | |
Mey, Ulrich | |
Lerch, Erika | |
Rhyner Agocs, Gaëlle | |
Goede, Jeroen | |
Maniecka, Zuzanna | |
Hayoz, Stefanie | |
Rüfer, Axel | |
Renner, Christoph | |
Driessen, Christoph |
Additional Credits
Series
Leukemia
Publisher
Springer Nature
ISSN
1476-5551
Access(Rights)
open.access